OxyContin 40 mg manufactured by Mundipharma is a prescription-only, prolonged-release (modified-release) formulation of oxycodone hydrochloride. It is a potent semi-synthetic opioid analgesic used primarily for the management of severe chronic pain that requires continuous, around-the-clock, long-term opioid treatment when other medications are inadequate Because it is a Schedule II controlled substance, it carries a high risk of addiction, physical dependence, misuse, and life-threatening respiratory depression Active Ingredient: Each tablet contains 40 mg of oxycodone hydrochloride Mechanism of Action: It binds to opioid receptors in the central nervous system to alter the perception of and emotional response to pain Prolonged-Release Mechanism: Mundipharma formulation is designed to slowly release the active drug into the bloodstream over a 12-hour period. This provides stable, long-lasting pain relief rather than a sudden spike in medication Abuse-Deterrent Properties: Modern OxyContin tablets produced by Mundipharma feature physical and chemical barriers. The tablets are highly break-resistant, making them difficult to crush, chew, or break for snorting or injection. When exposed to liquids, they turn into a thick gel that prevents syringing